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Abstract
During active surveillance at the Mediterranean Institute for
Transplantation and Advanced Specialized Therapies (ISMETT,
Palermo, Italy) with the CARBA screening medium, ﬁve pairs of
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneu-
moniae and Escherichia coli strains were isolated in each of ﬁve
colonized patients. In each patient, lateral gene transfer was
demonstrated by comparing K. pneumoniae and E. coli strains,
both possessing KPC-3, Tn4401a and pKpQIL-IT elements. The
isolates were found to be multiclonal by multilocus sequence
typing (sequence type (ST) 512 related to ST258, and ST307
belonging to a clonal complex different from the habitual
sequence clone ST258 isolated in Italy) and pulsed-ﬁeld gel
electrophoresis. The results of our study highlight the easy
transfer of KPC among Enterobacteriaceae colonizing the human
intestine, and the active and careful surveillance required to
identify and prevent the spread of these multidrug-resistant
microorganisms.
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Over the last 10 years, multidrug-resistant (MDR) Gram-neg-
ative Enterobacteriaceae has posed a substantial challenge to the
treatment of nosocomial infections, worsening the outcome of
hospitalized patients, particularly in those at high risk, such as
organ transplant recipients and patients undergoing specialized
surgery. In Italy, from 2009 to 2012, carbapenem-resistant
Klebsiella pneumoniae diffusion rose from 2.2% to 19.4%, with a
prevalence of K. pneumoniae carbapenemase (KPC) enzymes
[1].
The diffusion of KPC-producing K. pneumoniae strains
followed two different lines: (i) in the beginning, a unique
clone, ST258, was isolated in a number of countries around the
world; (ii) recently, new extensively drug-resistant clones have
appeared, evidence of the dissemination, by horizontal trans-
fer, of the mobile genetic elements carrying the blaKPC gene. In
fact, KPC enzymes are codiﬁed by genes frequently located in
the Tn4401, which is often carried on conjugative plasmids
that vary in size and structure [2,3]. In Italy, the most frequent
KPC-carrying plasmid is pKpQIL-IT [4]. The horizontal trans-
ferability of these elements, together with clonal expansion of
these MDR organisms, poses complex challenges to contain-
ment programmes and the planning of correct therapies. In
fact, infections sustained by MDR organisms harbouring blaKPC
genes are associated with therapeutic failure and high mortality
rates [5,6], particularly in high-risk patients.
In the light of this situation, an active search for KPC
producers colonizing immunocompromised patients, and
patients on the waiting list for transplant, is urgently required.
In May 2013, our institute, the Mediterranean Institute for
Transplantation and Advanced Specialized Therapies (IS-
METT), following an active rectal swab surveillance pro-
gramme with chromID CARBA agar (bio-Merieux Clinical
Diagnostics, Marcy l’Etoile, France), ﬁve pairs of KPC-produc-
ing K. pneumoniae (KPC Kp) and Escherichia coli (KPC Ec)
strains were isolated from each of ﬁve patients (two who
underwent organ transplantation, and three who underwent
cardiac surgery). At admission, these patients were colonized
with KPC Kp, and two developed bloodstream infection with
KPC Kp.
All rectal swabs at admission were inoculated on chromID
CARBA agar, and the suspected colonies with a pink/brown
colour were identiﬁed and tested for antibiotic susceptibility
with the BD PhoenixTM Automated Microbiology System,
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(Becton Dickinson, Franklin Lakes, NJ). Susceptibility results of
all the strains were conﬁrmed for imipenem, meropenem and
ertapenem by both microdilution and gradient test methods
(bio-Merieux). MIC breakpoints were interpreted according to
the European Committee on Antimicrobial Susceptibility
Testing guidelines [7]. All isolates were conﬁrmed by pheno-
typic testing for carbapenemase with aminophenyl boronic acid
and dipicolinic acid (Rosco Diagnostica, Taastrup, Denmark).
The results of the phenotypic conﬁrmation test were all
positive for KPC. The resistant determinants (blaKPC and
extended spectrum b-lactamase-encoding genes), and the
localization of blaKPC (Tn4401 and plasmid), were revealed
by PCR assay, using previously described primers [3].
Conjugation experiments were carried out on E. coli J-53 as
recipient and the transconjugants were selected with merope-
nem (4 mg/L) and rifampicin (300 mg/L). The identiﬁcation of
b-lactamase genes was performed by PCR [8]. No transcon-
jugants were obtained. In particular, the transconjugant
obtained with K. pneumoniae n. 429422 and E. coli J-53 showed
a very slight growth, insufﬁcient for molecular veriﬁcation, so
we could not determine conjugation.
Typing characterizations were performed by using pulsed--
ﬁeld gel electrophoresis and multilocus sequence typing, as
previously described [9,10].
The ﬁve strains of E. coli and K. pneumoniae presented
multiclonal macrorestriction proﬁles by pulsed-ﬁeld gel elec-
trophoresis, performed after XbaI digestion [11]. The pulsed--
ﬁeld gel electrophoresis clones coincided with sequence types
(STs) found by multilocus sequence typing (Table 1).
In E. coli, three pulsed ﬁeld gel electrophoresis clones and
three different STs were found: clone A was ST131, clone B
was ST1672, and clone C was ST394 [12]. The two pulsotypes
of K. pneumoniae (type A in two strains, and type B in three
strains) coincided with sequence types (STs) (clone A ST512
and clone B ST307) [12]. In particular, clone ST512 is a single
locus variant of ST258, already found in other Italian hospitals
[13], whereas there is no information on the presence of
K. pneumoniae ST307 in Italy.
Table 1 also shows the b-lactamase-encoding genes of the
isolates. All strains were conﬁrmed to harbour the blaKPC-3
and the blaTEM-1 genes. The only KPC Ec frankly resistant also
contained blaCTX-M-15. The same genes were found in the
co-cultured K. pneumoniae of the same patient. Plasmid analysis
was performed using extraction (QIAGEN Plasmid Mini Kit;
Qiagen, Les Ulis, France) and direct sequencing (3500 Genetic
Analyzer; Applied Biosystems, Carlsbad, CA), and revealed
that blaKPC-3 genes were in all cases embedded in a Tn4401a
transposon, and plasmid sequences matched for the presence
of the pKpQIL-IT in all strains under study [14].
Escherichia coli ST394 was previously not a KPC producer
but harboured extended spectrum b-lactamase genes
(blaCTX-M-15 and blaTEM-1); after 2 weeks the same clone was
isolated and was a KPC producer.
Among patients nos 427835, 427862 and 426010,
KPC-3-producing E. coli was acquired by cross-transmission
TABLE 1. Typing characterization of isolates by pulsed-ﬁeld
gel electrophoresis (PFGE) and multilocus sequence type
(MLST)
Patients Species PFGE ST
426814 Escherichia coli A 131
426814 Klebsiella pneumoniae B 512
427835 E. coli B 1672
427835 K. pneumoniae B 512
427862 E. coli B 1672
427862 K. pneumoniae B 512
426010 E. coli B 1672
426010 K. pneumoniae A 307
429422 E. coli C 394
429422 K. pneumoniae A 307
TABLE 2. Susceptibility to carbapenems measured by three methods of Klebsiella pneumoniae carbapenemase (KPC)-producing
strains
Patients Species Isolation date
MICs of carbapenems (mg/L)
Ertapenem BP (0.5/1) Meropenem BP (2/8) Imipenem BP (2/8)
Ph BMD Gradient test Ph BMD Gradient test Ph BMD Gradient test
426814 Escherichia coli 5/3/2013 >1 1 0.75 ≤1 0.5 2 ≤1 0.5 8
K. pneumoniae >1 128 >32 >8 >32 >32 >8 >32 >32
427835 E. coli 5/10/2013 >1 4 1.5 ≤1 1 0.75 4 1 3
K. pneumoniae >1 128 >32 >8 >32 >32 >8 64 >32
427862 E. coli 5/15/2013 >1 4 2 ≤1 4 2 4 1 4
K. pneumoniae >1 128 >32 >8 64 >32 >8 64 >32
426010 E. coli 4/30/2013 >1 1 1.5 ≤1 2 0.75 4 0.5 3 I
K. pneumoniae >1 128 >32 >8 256 >32 >8 256 >32
429422 E. coli 4/27/2013 <1 0.12 0.25 <1 0.12 0.06 <1 0.12 0.12
K. pneumoniae >1 128 >32 >8 512 >32 >8 512 >32
E. coli 5/11/2013 >1 >128 >32 >8 128 32 >8 64 32
K. pneumoniae >1 128 >32 >8 512 >32 >8 512 >32
Ph, Phoenix; BMD, microdiluition broth; BP, breakpoint.
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during hospitalization in the same ward. The route of
acquisition of both KPC producer strains is undetermined for
patient no. 426814 because he was positive at the admission
date and, moreover, the strain belonged to a different clone
(ST131). Table 2 summarizes the susceptibility testing of all
isolates. All K. pneumoniae strains were resistant to all carba-
penems with all methods used, whereas KPC Ec, possessed
lower MIC values compared with those observed in K. pneu-
moniae. In the KPC Ec strains, the automated Phoenix system
showed reduced susceptibility values to meropenem and
imipenem, with the sole exception of one isolate, fully resistant
to the three carbapenems with all methods. In the other four
strains, all susceptible by the Phoenix system, gradient testing
revealed a reduced susceptibility to carbapenems, with the
exception of ertapenem, which showed a resistant or inter-
mediate level with all methods used. In the light of these
ﬁndings, this drug was used as the marker of resistance.
Our paper highlights the simple, and worrisome, in vivo
inter-species transfer of pKpQIL-IT containing the blaKPC gene.
This event can be underappreciated and underreported
because of the low expression level of this resistance
determinant in a genetic background different from K. pneu-
moniae, as already observed [15]. Even if little is known about
the role that gene expression plays in KPC-mediated resis-
tance, or how the level of expression may affect susceptibility
testing, several hypotheses have emerged: (i) some studies
have reported a possible presence of different isoforms of
Tn4401 with different upstream promoters involved in
different degrees of expression [14]; (ii) the KPC gene can
be located in a low number of plasmid copies, as reported in
previous studies [15]. Further studies will be necessary to fully
understand this low level of expression in KPC Ec.
The ease of in vivo transfer of KPC between K. pneumoniae
and E. coli is extremely worrisome, and our study strengthens
the importance of infection control measures for rapid
detection of KPC in nosocomial pathogens, in order to
prevent further dissemination and, in case of infection, provide
direct targeted therapy.
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